INNOVATE BIOPHARMACEUTICLS I
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INNOVATE BIOPHARMACEUTICLS I COM PAR, CUSIP 45782F955.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INNOVATE BIOPHARMACEUTICLS I COM PAR, CUSIP 45782F955.